Francesca Tronconi Selected Research

Immune Checkpoint Inhibitors

10/2023	Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study.
1/2023	Potential immune‑related adverse events during dabrafenib and trametinib treatment: A case series of patients with BRAF V600E melanoma.
1/2021	Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesca Tronconi Research Topics

Disease

4	Neoplasms (Cancer) 10/2023 - 01/2021
2	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 12/2022
1	Melanoma (Melanoma, Malignant) 01/2023
1	Microsatellite Instability 12/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Ovarian Epithelial Carcinoma 01/2022
1	Chronic Disease (Chronic Diseases) 01/2021
1	Heart Failure 05/2011
1	Atrial Fibrillation 05/2011
1	Amyloidosis 03/2011

Drug/Important Bio-Agent (IBA)

3	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2021
2	PlatinumIBA 12/2022 - 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2023
1	LipidsIBA 10/2023
1	oxidized low density lipoproteinIBA 10/2023
1	Triglycerides (Triacylglycerol)IBA 10/2023
1	CholesterolIBA 10/2023
1	HDL LipoproteinsIBA 10/2023
1	trametinibIBA 01/2023
1	Melanoma-Specific AntigensIBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	dabrafenibIBA 01/2023
1	dostarlimabIBA 12/2022
1	lenvatinibIBA 12/2022
1	pembrolizumabIBA 12/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2022
1	Ribose (D-Ribose)IBA 03/2022
1	PM 01183IBA 01/2022
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	1,2,3,4-tetrahydroisoquinolineIBA 01/2022
1	GlucansIBA 01/2021
1	AutoantigensIBA 01/2021
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 03/2011

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2023 - 01/2021
3	Therapeutics 12/2022 - 05/2011
2	Immunotherapy 12/2022 - 01/2021